Renu Bhatia
Fortuna: 37 400 $ al 31/05/2026
Fortuna: 37 400 $ al 31/05/2026
Renu Bhatia currently holds the position of Lead Independent Non-executive Director at HUTCHMED (China) Ltd. starting in 2026.
Dr. Bhatia is also a Director at Opharmic Technology (HK) Ltd. Education history includes graduate studies at The University of Hong Kong, a doctorate from the University of London, and an MBA from Yale University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 10/03/2026 | 16.000 ( 0 % ) | 37 400 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| HUTCHMED (CHINA) LIMITED | Director/Miembro de la Junta | 13/05/2024 |
Opharmic Technology (HK) Ltd.
Opharmic Technology (HK) Ltd. Pharmaceuticals: MajorHealth Technology Develops ultrasonic ocular drug delivery platform | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
HUTCHMED (China) Ltd.
HUTCHMED (China) Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufactures, and sells pharmaceuticals and health oriented consumer products | Health Technology |
University of Hong Kong
University of Hong Kong Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of London
University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Opharmic Technology (HK) Ltd.
Opharmic Technology (HK) Ltd. Pharmaceuticals: MajorHealth Technology Develops ultrasonic ocular drug delivery platform | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.